Skip to main content
Premium Trial:

Request an Annual Quote

Evorion: Christian Scheiner, Helge Lubenow, Oliver Schacht, Steffen Bersch

Evorion Biotechnologies, a German developer of a high-content, single-cell assay system for functional phenomics, has appointed Christian Scheiner, Helge Lubenow, Oliver Schacht, and Steffen Bersch to its inaugural supervisory board.

Scheiner is CEO at Cilian, and has more than three decades of experience in the pharmaceutical and biotechnology industries. Lubenow is CEO at Proteomedix and has extensive experience in cancer diagnostics, personalized medicine, and clinical research. Schacht is president and CEO at OpGen, and has experience as a corporate finance executive in the molecular diagnostics industry. Bersch is CEO at SSI Schäfer Group, and has more than 15 years of experience specializing in corporate business development and governance.